We partnered with the executive team of a digital health technology company to refine their investment narrative, focusing on their unique value proposition, clinical trial results and regulatory pathway for market approval. The challenge involved communicating complex medical technology benefits to both healthcare and technology investors.
We developed comprehensive investor pitch decks highlighting clinical efficacy data, regulatory approval timelines and commercial opportunities across multiple healthcare markets. Our detailed business plans included financial models reflecting various funding scenarios, market penetration assumptions and scaling strategies. We provided extensive investor presentation coaching, preparing the management team for rigorous due diligence processes and technical questioning from sophisticated healthcare investors. The preparation included development of detailed data rooms, regulatory documentation summaries and intellectual property portfolios.
Our fundraising support secured over £15 million in Series B funding from a combination of venture capital firms and strategic healthcare investors, exceeding the client’s initial funding target by 26%. The successful raise enabled expansion of clinical studies, acceleration of regulatory approval processes and development of additional product features that strengthened market positioning.